| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |